ArticleInvestigational new drugs2013

A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.

Balazs Halmos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.